Related Experiment Video
Updated: Aug 17, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Video-assisted thoracoscopic surgical excision of cystic lung disease in children
Curt S Koontz1, Virginia Oliva, Kenneth W Gow
1Division of Pediatric Surgery, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, GA 30322, USA.
Insights
Video-assisted thoracoscopic surgery (VATS) is a safe and effective method for treating pediatric cystic lung disease (CLD). This minimally invasive approach offers advantages for children requiring lung lesion resection.
Area of Science:
- Pediatric Surgery
- Thoracic Surgery
- Medical Technology
Background:
- Cystic lung disease (CLD) encompasses various congenital pulmonary abnormalities in children.
- Traditional thoracotomy can be associated with significant morbidity in pediatric patients.
- Minimally invasive surgical techniques are increasingly explored for pediatric thoracic conditions.
Purpose of the Study:
- To evaluate the safety and efficacy of video-assisted thoracoscopic surgery (VATS) for the resection of cystic lung disease (CLD) in pediatric patients.
- To compare the potential advantages of VATS over traditional thoracotomy for CLD management in children.
Main Methods:
- A retrospective review of 6 pediatric patients who underwent VATS for CLD between September 1999 and August 2004.
- Patients were selected for VATS at the surgeon's discretion.
- Data collected included patient demographics, lesion type, surgical procedure, operative time, and postoperative outcomes.
Main Results:
- The study included diverse CLDs such as congenital cystic adenomatoid malformations, extrapulmonary sequestrations, congenital lobar emphysema, and bronchogenic cysts.
- VATS procedures involved lobectomy or simple excision.
- Key outcomes demonstrated short chest tube duration (1.2 days), minimal postoperative pain (low morphine use), and brief hospital stays (2.5 days), with no conversions to thoracotomy or complications.
Conclusions:
- Video-assisted thoracoscopic surgery (VATS) is a safe and effective treatment modality for pediatric cystic lung disease across all age groups.
- The minimally invasive nature of VATS in this cohort resulted in favorable short-term outcomes.
- Further research with larger patient cohorts is warranted to solidify these findings.
Purpose:
Video-assisted thoracoscopic surgical (VATS) technique for resection of cystic lung disease (CLD) may offer some advantages when compared with thoracotomy in children.
Methods:
From September 1999 to August 2004, 6 pediatric patients underwent VATS for CLD. Patients were chosen for VATS based upon surgeon's choice. Data are expressed as mean +/- SD. The Children's Healthcare of Atlanta institutional review board approved this study.
Results:
The types of lesions included congenital cystic adenomatoid malformations (n = 1), extrapulmonary sequestrations (n = 3), congenital lobar emphysema (n = 1), and bronchogenic cyst (n = 1). The extent of resection included lobectomy (n = 2) and excision (n = 4). Age and weight were 11.8 +/- 18 months (range 6 days to 4 years) and 7.5 +/- 3.6 (range 4.0-14.0) kg, respectively. Operating time was 103 +/- 70 (range 38-223) minutes. Chest tube duration was 1.2 +/- 0.8 (range 0-2) days. Morphine use on the first postoperative day was 0.2 +/- 0.3(range 0.05-0.20) mg/kg. Length of stay was 2.5 +/- 1.9 (range 1-6) days. There were no conversions to thoracotomy and no complications.
Conclusion:
VATS technique appears to be a safe and effective technique in managing CLD in children of all ages. More patients, however, need to be studied.
Related Concept Videos
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due to...
Pneumothorax-II
Clinical Manifestations:
